The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Immunization Safety Review: Multiple Immunizations and Immune Dysfunction
Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. 2000. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 343:538–543.
Barnes KC. 2000. Atopy and asthma genes—where do we stand? Allergy. 55:803–817.
Barrios C, Brawand P, Berney M, Brandt C, Lambert PH, Siegrist CA. 1996. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 26:1489–1496.
Ben-Nun A, Mendel I, Kerlero de Rosbo N. 1997. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: The protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer. Proc Assoc Am Physicians. 109:120–125.
Ben-Nun A, Yossefi S, Lehmann D. 1993. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis. Eur J Immunol. 23:689–696.
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 27:20–21.
Benoist C, Mathis D. 2001. Autoimmunity provoked by infection: How good is the case for T cell epitope mimicry? Nat Immunol. 2:797–801.
Black SB, Cherry JD, Shinefield HR, Fireman B, Christenson P, Lampert D. 1991. Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. Am J Dis Child. 145:746–749.
Blackwelder WC. 1995. Similarity/equivalence trials for combination vaccines. Ann NY Acad Sci 754:321–328.
Blankenhorn EP, Butterfield RJ, Rigby R, Cort L, Giambrone D, McDermott P, McEntee K, Solowski N, Meeker ND, Zachary JF, Doerge RW, Teuscher C. 2000. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: An environmental agent can override genetic checkpoints. J Immunol. 164:3420–3425.
Blom L, Nystrom L, Dahlquist G. 1991. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia. 34:176–181.
Brodsky AL. 1972. Atypical measles. Severe illness in recipients of killed measles virus vaccine upon exposure to natural infection. JAMA. 222:1415–1416.
Bryan SA, O’Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock JA, Boyce MJ, Hansel TT, Holgate ST, Barnes PJ. 2000. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 356:2149–2153.
Burstein JL, Fleisher GR. 1994. Does recent vaccination increase the risk of occult bacteremia? Pediatr Emerg Care. 10:138–140.
Busse WW, Lemanske RF Jr. 2001. Asthma. N Engl J Med. 344(5):350–362.
CDC (Centers for Disease Control and Prevention). 1999a. Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. Morb Mortal Wkly Rep(MMWR) 48(26):563–565.
CDC. 1999b. Withdrawal of rotavirus vaccine recommendation. MMWR. 48(43):1007.
CDC. 1999c. Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 48(RR-12);1– 37.